Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio, Digilab Join in Co-marketing, R&D Effort

NEW YORK (GenomeWeb News) – Pressure BioSciences and Digilab have struck an agreement to co-market and sell their product lines together worldwide and to pursue joint research and development projects, Digilab said today.

The companies plan to co-market their respective technologies through industry publications, at scientific meetings, through their websites, at trade shows, and through common collaborator studies.

Under the R&D collaboration, PBI and Digilab plan to co-develop new instruments, accessories for existing instruments, and consumables that combine Digilab's robotics and high-throughput capabilities with PBI's Pressure Cycling Technology platform.

According to Digilab, a combination of the companies' respective platforms will provide an improved, more reproducible, and integrated workflow for addressing a number of sample prep issues that researchers face.

"We believe that Digilab's suite of sample preparation, liquid handling, and identification products, coupled with PBI's unique pressure-based technology platform and PCT products, will offer the research scientist greatly enhanced sample preparation tools with a higher degree of reproducibility, versatility, throughput, and overall quality than currently available," Digilab Chairman and CEO Sidney Braginsky said in a statement.

PBI's President and CEO Richard Shumacher said that the collaboration with Digilab will enhance its sales, marketing, and distribution activities and that its team will help Digilab broaden its sales capabilities.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.